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High quality medical assistance and preventive strategies, including pursuing a healthy
lifestyle, result in a progressively growing percentage of older people. The population and
workforce is aging in all countries of the world. It is widely recognized that older individuals
show an increased susceptibility to infections and a reduced response to vaccination
suggesting that the aged immune system is less able to react and consequently protect
the organism. The SARS-CoV-2 pandemic is dramatically showing us that the organism
reacts to novel pathogens in an age-dependent manner. The decline of the immune
system observed in aging remains unclear. We aimed to understand the role of B cells. We
analyzed peripheral blood from children (4-18 years); young people (23-60 years) and
elderly people (65-91 years) by flow cytometry. We also measured antibody secretion by
ELISA following a T-independent stimulation. Here we show that the elderly have a
significant reduction of CD27dull memory B cells, a population that bridges innate and
adaptive immune functions. In older people, memory B cells are mostly high specialized
antigen-selected CD27bright. Moreover, after in vitro stimulation with CpG, B cells from
older individuals produced significantly fewer IgM and IgA antibodies compared to
younger individuals. Aging is a complex process characterized by a functional decline in
multiple physiological systems. The immune system of older people is well equipped to
react to often encountered antigens but has a low ability to respond to new pathogens.
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The progressive deterioration of the immune system in aged
individuals is termed “immunosenescence” (1). This process
entails an impairment of the immune response with a
consequent increased susceptibility to emerging pathogens and
a reduced responsiveness to vaccination (2–4). As a consequence,
older individuals showed an increased morbidity (4) and
mortality (5).
The aging of workers is one of the most important issues for
occupational health and safety in Europe. The EU’s demographic
old-age dependency ratio (i.e., the ratio between people aged 65
years and over and those aged 20-64) is projected to increase
significantly in the coming decades. From about 29% in 2010, it
is projected to rise to 59% in 2070 (6). Labor force participation is
projected to increase, in particular among older workers, on
account of implemented pension reform. Keeping workers active
and productive through health promotion intervention is a
prime objective of European labor policy (7, 8). This task
requires adapting work environments to the changing
characteristics of the workforce, taking into account the high
prevalence of chronic diseases in older workers and their greater
sensitivity to infections (9). The SARS-CoV-2 pandemic is
dramatically showing us that the organism reacts to novel
pathogens in an age-dependent manner. Disease severity and
mortality rate are highest in the elderly, especially when co-
existing morbidities further weaken the organism (10, 11)
rendering the immune response against the virus less effective
(12–14).
With aging, the organism experiences a progressive
impairment of both the innate and adaptive arm of the
immune system (1), where thymic involution and the
decreased output of T cells are probably the most recognized
signs (15). Many other immune cell functions are affected by
aging, such as reduced antigen-presenting and cytokine secretion
ability of macrophages and follicular dendritic cells (16, 17) and
diminished neutrophils phagocytic activity (18). In addition, T
cell repertoire and T cell responsiveness are reduced (19, 20).
On the other hand, the role of B cells in immune aging
remains unclear. Recent findings illustrate major shifts in B cell
subsets in the elderly, suggesting that age-related changes in B
cells may contribute to immunosenescence (21).
Immunological memory is the ability of our immune system
to remember previously encountered pathogens; it is acquired by
experience and it changes throughout life affecting our
susceptibility to infections. Neonates and children under 5
years are more susceptible to infections compared to adults,
because they are continuously exposed to pathogens that they
have never encountered before (22). Infections are rare in adults
thanks to their large repertoire of specific memory T and B cells
generated by previous antigenic experiences. In the elderly,
susceptibility to infections increases again (23).
Respiratory tract infections are a major cause of disease
during old age (24) when the response to vaccination is
decreased (25). Encapsulated bacteria (mostly Streptococcus
pneumoniae) are the main cause of respiratory tract infections
and a leading cause of mortality in people >65 years old (26).Frontiers in Immunology | www.frontiersin.org 2As for respiratory infections, also gastrointestinal infectious
diseases in the elderly are common (27) suggesting that
mucosal immune responses could be compromised (24).
We focused our attention on B cells that change with age in
number and type (21). As a result of infection or vaccination, B
cells become memory B cells (MBCs) and plasmablasts (PBs)
able to produce high affinity antigen-specific antibodies. MBCs
can be identified by the expression of the CD27 marker (28). The
intensity of expression of CD27 defines two populations,
CD27dull and CD27bright MBCs.
CD27dull MBCs can be generated without T cells and
germinal center (GC) and are mostly of the IgM isotype.
Instead, CD27bright MBCs are generated exclusively in the GC
by a T cell-dependent mechanism and under a strong selective
pressure by an antigen (Ag). For this reason, the frequency of
somatic mutations (SMs) is low in CD27dull MBCs and
significantly higher in CD27bright MBCs (28). We have shown
that CD27dull MBCs are the precursors of the CD27bright MBCs
and that the human MBC pool is organized in large clones with a
root of CD27dull MBCs of the IgM isotype, gradually acquiring
more SM and finally generating highly mutated MBCs of IgM or
switched isotypes. CD27bright MBC are closer to the plasma cell
stage than CD27dull MBCs. In a previous study, we sorted
CD27dull and CD27bright MBCs and demonstrated that upon
stimulation CD27bright MBCs undergo rapid and extensive
proliferation and differentiate in large number of plasmablasts
more effectively than CD27dull MBCs (28).
The reduction of CD27dull IgM MBCs correlates with an
impaired immune response to encapsulated bacteria in infants,
splenectomized and asplenic individuals, and patients with
primary or secondary immune deficiency (29). With age, IgM
MBCs decrease (30). Moreover, aging has an impact on the
splenic marginal zone (MZ) that is known to be the site where
CD27dull IgM MBCs (31, 32) are located.
Here we show that, compared to children, elderly individuals
have more CD27bright MBCs, suggesting that their immune
system may be equipped to react against well-known antigens
but has a reduced ability to respond to new pathogens.
Moreover, after in vitro stimulation with CpG, B cells from
elderly individuals produced significantly fewer IgM and IgA
antibodies compared to younger individuals.MATERIALS AND METHODS
Ethical Approval
Ethical approval was obtained from the Ethics Committee at the
Bambino Gesù Children Hospital. According to the guidelines
on Italian observational studies as established by the Italian
legislation about the obligatory occupational surveillance and
privacy management, health care workers’ confidentiality was
safeguarded and informed consent was obtained from all the
participants. The study was performed in accordance with the
Good Clinical Practice guidelines, the International Conference
on Harmonization guidelines, and the most recent version of the
Declaration of Helsinki.July 2021 | Volume 12 | Article 690534
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We analyzed peripheral blood from children (4-18 years); young
people (23-60 years) and elderly people (65-91 years). Young and
elderly individuals were health care workers from our hospital,
the majority of whom were active, while others were already
retired. Older individuals were screened by interview to ensure
they did not have autoimmune diseases, tumors, or
recent infections.
At the time of blood sampling, none of the subjects had an
acute infection or were taking any medication known to alter
immune function (such as steroids or statins).
Cell Isolation
Heparinized peripheral blood was collected and then centrifuged
through a Histopaque gradient (Ficoll Paque™ Plus 206,
Amersham Pharmacia Biotech) for 25 min at 2400 rpm.
PBMCs were collected from the interface. Next, PBMCs were
spun down and washed twice with RPMI 1640 medium
(Euroclone). Then PBMCs were frozen and stored in liquid
nitrogen until use. The freezing medium contained 90% Fetal
Bovine Serum (FBS) and 10% DMSO.
Stimulation and Reagents
PBMCs were loaded with Carboxyfluorescein succinimidyl ester
(CFSE, Life Technologies). Briefly, 1x106 cells/ml were
resuspended in PBS (Euroclone) with 1% FBS (Gibco BRL)
and loaded with 1mM CFSE for 20 min at 37°C. After washing,
cells (at a concentration of 5x106 cells/ml) were stimulated with
0.35 mM of TLR9 agonist CpG-B ODN2006 (Hycult Biotech) in
complete medium for 5 days at 37°C. Complete medium was
prepared as follows: RPMI-1640 (Euroclone), 10% heat
inactivated fetal bovine serum (FBS, Hyclone Laboratories), 1%
L-Glutammine (Gibco BRL); 1% Penicillin/Streptomicin 100X
(Euroclone), 1% sodium pyruvate (Gibco BRL).
ELISA Immunoassay
Following CpG stimulation (5 days), we performed an ELISA to
detect secreted immunoglobulin in the supernatant of the
stimulated cells. Briefly, 96-well plates (Costar3590 EIA/RIA
plate) were coated overnight with purified goat anti-human
IgA+IgG+IgM (H+L chain; Jackson ImmunoResearch
Laboratories). After washing with PBS containing 0.05%
Tween and blocking with PBS containing 1% gelatin (1 h,
room temperature), plates were incubated for 1 h at 37°C with
the supernatants of cultured cells. After removing the
supernatants and washing, plates were incubated for 1 h with
peroxidase-conjugated fragment goat anti-human IgA or IgG or
IgM antibodies (Jackson ImmunoResearch Laboratories). The
assay was developed with O-phenylendiamine tablets (Sigma-
Aldrich) as a chromogenic substrate. Absorbance at 450 nm was
measured, and immunoglobulin concentrations were calculated
by interpolation with the standard curve.
Flow Cytometry and Antibodies
A total of 50 ul of total peripheral blood was used for
enumeration of CD45+ cells using the DuraClone IM Count
(Beckman Counter) following the manufacturer’s instructions.Frontiers in Immunology | www.frontiersin.org 3PBMCs were stained with the appropriate combination of
fluorochrome-conjugated antibodies to identify B cell subsets
according to standard techniques. Used antibodies were: CD19,
CD21, CD24, CD27, CD38, IgG, IgA, and IgM (Table S1).
Acquisition was performed on a BD LSRFortessa X-20 (BD
Biosciences) and data were analyzed with FlowJo ver.8
(Treestar). Proliferation was measured through the analysis of
CFSE dilution. The FlowJo’s Proliferation tool looks for a pattern
typically expressed by cells loaded with fluorescent dye (CFSE in
our case) and is allowed to divide. The FlowJo’s Proliferation
platform calculates the proliferation index (PI) that corresponds
to the mean number of divisions of all cells that have responded
(Proliferation Index: Total Number of Divisions/Cells that went
into division). We also calculated the replication index (RI) that
indicates the fold-expansion of only the responding cells
(Replication Index: Total Number of divided cells/The number
of cells that went into division). These two indices reflect the
intrinsic ability of the different cell types to respond to
signals (33).Statistical Analysis
Values were compared by the non-parametric Kruskal-Wallis
test and, if significant, pairwise comparisons were evaluated by
the Mann-Whitney U test nonparametric test. A level of p < 0.05
was considered statistically significant. * p < 0.05; **p < 0.01, and
***p < 0.001.RESULTS
Immunophenotype of B Cells
We determined the frequencies and absolute numbers of B cell
populations of children (n=37; 4-18 years) and adults of different
ages (20-40 years, n=18);, (65≥ years <70, n=21) and over 70
years (n=9). We excluded infants from our analysis because their
memory B cell pool is mainly represented by CD27dull MBCs.
Peripheral blood mononuclear cells (PBMCs) were stained with
antibodies to CD19, CD21, CD24, CD27, CD38, CD45, and IgM.
The gating strategy used to identify B cell population is shown in
Figure S1. Absolute numbers were calculated by staining blood
samples with the DuraClone IM Count (Beckman Counter).
Children have the highest frequency of B cells in the
peripheral blood compared to adults of all ages, (CD19+)
(Figure 1A) (19). B cells are increased in absolute numbers in
young adults probably because of an overall increase in the
CD45+ lymphocytes count (Figure 1A). The percentages of
naïve B cells (CD19+, CD24+, CD27-) appears to be similar in
the four groups but absolute numbers indicate a significant
decrease in the elderly group probably because of the reduction
of total B cells (Figure 1B). Transitional B cells (CD19+, CD24+,
CD38++), the most immature B cell subtype in the blood, are
highest in children and significantly decrease with age, both in
percentage and absolute numbers (Figure 1C).
The percentage of MBCs (CD19+, CD24+, CD27+) is
significantly increased in the young and older adult groups
compared to children (Figure 1D). As for naive B cells, theJuly 2021 | Volume 12 | Article 690534
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numbers and the young group has the highest value compared
to the others (Figure 1D). In contrast, the percentage of
plasmablasts (CD19+, CD27+, CD38++) significantly increased
in the over 70 group (Figure 1E). Atypical memory B cells
(ATM) have been described in aged mice and are distinct from
other B cell subsets (34, 35). In humans, they increase in the
course of autoimmune diseases (35–37) and infections (38–40),
and are thought to reflect a failure or impairment of the germinal
center reaction (41). Both percentage and absolute number of
ATM (CD19++, CD24-, CD38-, CD21-) were increased in the
elderly group (Figure 1F) (42).
CD27dull and CD27bright Memory B Cells
CD27 is the marker that allows the identification of MBCs. Our
group have recently demonstrated that MBCs comprise two cell
populations, CD27dull and CD27bright MBCs, which are related
but have distinct molecular signatures and functions (28). Thus,
we examined CD27 intensity in our different age groups. The
gating strategy to identify the two MBCs population of each
group (gated in CD19+ B cells) is shown in Figure 2A. We
observed a significant reduction in percentage and absolute
number of CD27dull MBCs in the two groups of older people
compared to young adults (Figure 2B). Instead, the percentage
of CD27bright MBCs is significantly lower in the children groupFrontiers in Immunology | www.frontiersin.org 4compared to the other groups (Figure 2C). Interestingly, the
absolute number of CD27bright MBCs is significantly increased in
the young group, probably because of the higher number of total
B cells compared to the other groups (Figure 2C).
For our health, it is important to have both CD27dull and
CD27bright MBCs since they play different and non-
interchangeable roles (28). In order to evaluate the relative size
of the two pools, we calculated the ratio between the absolute
numbers of CD27dull and CD27bright MBCs at different ages. We
found that in the older groups the ratio is significantly lower
compared to the two youngest groups (Figure 2D), confirming a
dramatic reduction of CD27dull compared to CD27bright MBCs.
CpG Stimulation
The imbalance of B cell frequency is undoubtedly important,
nevertheless it is essential to evaluate the ability of B cells to
respond to stimuli. Upon T-independent (TI) stimulation with
CpG, a ligand of the toll-like receptor 9 (TLR9), B cells proliferate,
differentiate into plasmablasts (identified as CD19low, CD27++,
CD38++), and secrete immunoglobulins (43).
In order to prove their function, PBMCs of children, young
and elderly people were cultured for 5 days with CpG and then
analyzed by flow cytometry. By ELISA, we measured the amount
of IgM, IgG, and IgA in the culture supernatants. Due to the low




FIGURE 1 | Percentage and absolute numbers of (A) B cells; (B) naïve B cells; (C) transitional B cells; (D) memory B cells (MBCs); (E) plasmablasts, and
(F) atypical MBCs (ATM) at the indicated ages (children n = 37; young n = 18; 65 ≥years <70 n = 21; over 70 years n = 9). Midlines indicate the median values.
Statistical significances were determined using unpaired, two-tailed Mann-Whitney U-tests. *p ≤ 0.05; **p < 0.01; ***p < 0.001.July 2021 | Volume 12 | Article 690534
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and 2 subjects of the 65≥ years <70 were excluded).
FACS analysis of four representative samples is reported in
Figure 3, and the histogram depicts the B cell proliferation
evaluated by tracking the dilution of the fluorescent dye CFSE.
The percentage of in vitro-produced plasmablasts was similar
between the four groups (Figure 4A), suggesting that the ability
of MBCs to differentiate in plasmablasts following a TI
stimulation is not affected in elderly people. We evaluated also
the proliferation and replication index values. The proliferation
index is the average number of divisions that all responding
cells have undergone since the initiation of the culture and
reflects the proliferative capacity of the cells in response to
CpG. This index is calculated by dividing the total number of
cells that proliferated by the number of cells that went
into division.
The replication index determines the fold-expansion of only
responding cells and reflects the expansion capacity of the
replicating cells rather than the entire culture.
The two indexes were significantly higher in the two oldest
groups compared with the children and with the young
group (Figure 4B).
Although B cells from older groups proliferate and replicate
extensively and differentiate into PB, they secrete fewer
immunoglobulins. In particular, IgM and IgA levels wereFrontiers in Immunology | www.frontiersin.org 5significantly reduced in the two groups of older people and the
level of IgG was reduced in the over 70 group (Figure 4C).DISCUSSION
High quality medical assistance and preventive strategies,
including pursuing a healthy lifestyle, result in a progressively
growing percentage of older people in life and the working
environment. It is widely recognized that older individuals
show an increased susceptibility to infections and a reduced
response to vaccination suggesting that the immune system is
less able to react and consequently protect the organism. This
represents a burden on health care costs and furthermore raises
the question of which interventions may guarantee a good
quality of life and reduce the risk of avoidable age-related
diseases. The current COVID-19 pandemic emergency has
strongly demonstrated that older individuals are more fragile
when challenged by an unknown pathogen, fostering the need to
understand which mechanisms differentiate the aged immune
system from that of a young individual.
It has been recently published (44) that the different responses
between young and older individuals are due to the different





FIGURE 2 | (A) Identification of naive, CD27dull, and CD27bright MBCs at the indicated ages. (B, C) Percentage and absolute numbers of (B) CD27dull and
(C) CD27bright MBCs. (D) Ratio of CD27dull and CD27bright MBCs at the indicated ages (children n = 37; young n = 18; 65 ≥years <70 n = 21; over 70 years n = 9).
Midlines indicate the median values. Statistical significances were determined using unpaired, two-tailed Mann-Whitney U-tests. *p ≤ 0.05; **p < 0.01; ***p < 0.001.July 2021 | Volume 12 | Article 690534
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B cells, we performed a cytofluorimetric and functional study of
B cells in the peripheral blood of children and young blood
donors and compared them to two groups of older individuals
divided according to age (65≥ years <70 or over 70 years). To
avoid health–related bias, we enrolled individuals in the study
that did not have an associated co-morbidity or previous diseases
of the immune or hematopoietic system.
Besides a general age-related reduction in the percentage of
CD19+ B cells, we found specific changes in B cell
subpopulations. While naïve, transitional, and MBCs were
reduced in either or both percentages and total numbers, we
observed an increase in both the percentage and the absolute
number of ATM B cells in older individuals compared to young.
These cells have been identified in different contexts that include
chronic infection, autoimmunity, and aging (45).
CD27dull MBCs in older people were significantly reduced both
in percentage and absolute number, as well as the ratio between
CD27dull and CD27bright. We have previously demonstrated that
CD27dull MBCs aremostly of the IgM isotype and can be generated
without T cells and GC (28). CD27dull MBCs are the precursors of
CD27brightMBCs.While CD27brightMBCs produce antibodies that
are highlymutated, CD27dullMBCs are lessmutated andmay enterFrontiers in Immunology | www.frontiersin.org 6the GC reaction in competition with naïve B cells, having the
advantage of amore suited transcriptome compared to naïve B cells
(28). Thus the reduction of CD27dull MBCs not only explains the
reduction of IgM MBCs observed in the elderly (21) but also
explains the diminished ability of elderly people to react to new
infections and vaccinations associated with the increased incidence
and severity of infections (46).
The dramatic reduction of CD27dull MBCs in older individuals
can explain the reduction of TI immune responses, such as those
against Streptococcus pneumoniae (29). Interestingly, the
susceptibility to pneumococcal infection is high in neonates
whose CD27dull MBCs population is still scarce, reduced in the
young and adult populations, where CD27dull MBCs are abundant,
and increased again in the elderly (46).
The significant reduction of CD27dull MBCs also has an
impact on sIgA synthesis. We have recently demonstrated that
IgM MBCs are necessary for the production of sIgA at the
mucosal surface (47). sIgA is the major player for host defense,
providing a first line of effective immunity against pathogens at
mucosal sites. The gastrointestinal tract in the elderly is
particularly susceptible to infectious diseases, suggesting that
poor mucosal immunity is responsible for the higher mortality to
infections in aged individuals (48). Interestingly, it has beenFIGURE 3 | Dot plots show the gating strategy used to identify plasmablasts (PBs), CD19+, CD27++, and CD38++ in vitro; in four representative PBMCs, one for
each group. Histograms show CFSE.July 2021 | Volume 12 | Article 690534
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antibody resulting in age-related decline in mucosal
immunity (49).
B cells fight viruses and bacteria by producing antibodies
following their differentiation into circulating plasmablasts. The
percentage of plasmablasts increased with age and the ability of
the B cells to proliferate and differentiate into plasmablasts seems
to not be affected or even improved in older subjects because of
the increase of CD27bright MBCs that are closer to the plasma cell
stage than CD27dull MBCs (28). However, our results from the in
vitro studies indicate an impairment of the B cells’ function
following a TI stimulus and confirm that the most affected
antibodies are IgM and IgA.
Thus, the observed plasmablasts number associated with a
reduced level of secreted antibodies suggest an impaired capacity
to exert their function with age.
Aging is associated with the accumulation of damaged
mitochondria, that are less efficient in ATP generation (50).
Several studies indicate that autophagy-related (ATG) proteins
and other proteins required for autophagy induction, such as
Sirtuin 1, are less expressed in aged tissues and that autophagy
diminishes with aging (51). Atg5-/- murine plasma cells show
augmented endoplasmic reticulum stress and cell death, failing to
give rise to an efficient antibody response and to form long-lived
plasma cells in vivo (52). Atg5f/f CD19-Cre mice have reduced IgM
and IgG responses in both TI and T-dependent immunization
experiments, revealing a key adaptive role of autophagy in short-
lived plasma cells and in antibodies responses (52).
Taken together these observations suggest that the defects in
autophagy observed in the elderly may explain the functionalFrontiers in Immunology | www.frontiersin.org 7impairment of immunoglobulin secretion by plasmablasts that
we have demonstrated in our experiments.
Understanding how the aging of the immune systemworks is an
important step to protect one of the most sensitive groups of our
population, especially in this present pandemic era. In some
countries, including Italy, governments have issued special
emergency regulations that oblige employers to implement
special biohazard prevention measures for older workers (53).
Among these measures, the provision of vaccines for older
workers who are exposed to biohazards is of the utmost
importance. Indeed, a recent report highlights novel aging-related
genes and adaptive immune dysregulation with potential
contributions to the high severity rate of aged COVID-19 patients
(54). Thus, vaccination programs may be implemented for
individuals that are between 65 and 70 as well as for workers of
older age (over 55 years) in order to improve their protection to be
used when the natural immune resources start to fail.
The number of subjects in the over 70 years old group is a
limitation of our study. Nevertheless, the results are very
homogenous and we have been extremely selective during the
recruitment. Healthy elderly people represent <15% of the
general older population (55) and therefore the subjects who
responded to our requirements were rare.DATA AVAILABILITY STATEMENT
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